Trials / Completed
CompletedNCT01630161
Smoking Relapse-Prevention Intervention for Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 441 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.
Detailed description
This study involves participation at four distinct time points over a one-year period. * Baseline assessment * 2-month follow-up telephone call * 6-month follow-up telephone call * 12-month follow-up telephone call
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Usual Care | Standard care includes routine assessment of smoking behavior and brief clinical intervention. Smoking counseling for all participants in the current study will be completed by a Certified Tobacco Treatment Specialist consisting consists of brief counseling (\<15 minutes) based on the 5 A's Clinical Practice Guidelines; Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, Arrange for follow-up (Fiore et al., 2008). Patients receive information for local and state smoking resources (e.g., Quitline), pharmacotherapy options, and if interested, assistance with obtaining a prescription for pharmacotherapy. Follow-up with patients occurs at 2-weeks, only among those who are prescribed smoking medications (i.e., Varenicline, Bupropion). |
| BEHAVIORAL | Smoking Relapse Prevention for Cancer Patients (SRP-CaP) | The proposed multimodal intervention consists of a series of easy-to-read relapse prevention booklets (Forever Free) that have shown to be efficacious with a general smoking population (Brandon et al., 2000; 2004), and digital video disk (DVD) customized to the needs of cancer patients (to be developed in Year One). |
Timeline
- Start date
- 2012-01-04
- Primary completion
- 2015-05-15
- Completion
- 2020-11-18
- First posted
- 2012-06-28
- Last updated
- 2021-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01630161. Inclusion in this directory is not an endorsement.